GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Thermo Fisher Scientific Inc (TMO) [hlAlert]

Rating:
Buy TMO
up 147.79 %

Thermo Fisher Scientific Inc (TMO) rated Buy with price target $73 by Auriga U.S.A

Posted on: Wednesday,  May 11, 2011  8:25 AM ET by Auriga U.S.A

Auriga U.S.A rated Buy Thermo Fisher Scientific Inc (NYSE: TMO) on 05/11/2011. Previously Auriga U.S.A rated Buy Thermo Fisher Scientific Inc (NYSE: TMO)
on 11/10/2010., when the stock price was $51.62. Since then, Thermo Fisher Scientific Inc has gained 147.79% as of 01/08/2016's recent price of $127.91.
If you would have followed the previous Auriga U.S.A's recommendation on TMO, you would have gained 147.79% of your investment in 1885 days.

Thermo Fisher Scientific Inc. (Thermo Fisher), incorporated in 1956, is engaged in serving science. It provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The Company operates through two segments: analytical technologies and laboratory products and services. Analytical technologies segment includes pharmaceutical, biotechnology, academic, government and other research and industrial markets. Laboratory products and services segment offers combination of products and services that allows its customers to engage in their core business functions of research, development, manufacturing, clinical diagnosis and drug discovery. In April 2009, Alesco Corporation Ltd. sold its Scientific & Medical division to Thermo Fisher Scientific Inc. In October 2009, the Company acquired B.R.A.H.M.S. AG.

Auriga is committed to providing our clients with market information flow, investment ideas and access to industry experts. We strive to provide value through unique industry knowledge. Our growing research practice is being built with domain experts who have a strong reputation amongst institutional investors. Auriga’s research analysts have also been recognized by numerous industry publications including, The Wall Street Journal and Bloomberg. Our bottom-up fundamental approach is data point driven with a primary focus on growth sectors within the technology and healthcare verticals.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/11/2011 8:25 AM Buy
None
61.08 73.00
as of 12/30/2011
1 Week down  -1.57 %
1 Month down  -4.82 %
3 Months down  -11.19 %
1 YTD down  -18.76 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/10/2010 8:25 AM Buy
None
51.62 66.00
9/7/2010 8:25 AM Hold
None
45.08 50.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy